Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature

Case Rep Endocrinol. 2018 May 9;2018:4606491. doi: 10.1155/2018/4606491. eCollection 2018.


Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.

Publication types

  • Case Reports